about
B7-H5 costimulates human T cells via CD28HMolecular mechanisms of T cell co-stimulation and co-inhibitionCD28 co-stimulation in T-cell homeostasis: a recent perspectiveParticipation of blood vessel cells in human adaptive immune responsesTargeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cellsBlockade of the B7-H1/PD-1 pathway for cancer immunotherapyAdvantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28Immunotherapeutic strategies in autoimmune uveitisTargeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.Cell surface signaling molecules in the control of immune responses: a tide model.Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunityThe role of coinhibitory signaling pathways in transplantation and toleranceThe role of B7 family molecules in hematologic malignancyAntagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domainNeuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEMHHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell functionAdvances in targeting cell surface signalling molecules for immune modulationThe clinical impact of ICOS signal in colorectal cancer patientsCostimulation Blockade in Kidney Transplantation: An UpdateIntratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity.T cell costimulation and coinhibition: genetics and disease.Belatacept: from rational design to clinical application.The B7 homologues and their receptors in hematologic malignancies.CD28-specific immunomodulating antibodies: what can be learned from experimental models?MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.Belatacept: a new era of immunosuppression?B7 family checkpoint regulators in immune regulation and disease.Targeting co-stimulatory pathways: transplantation and autoimmunity.Emerging Co-signaling Networks in T Cell Immune Regulation.Targeting CD28 to prevent transplant rejection.Blood and beyond: properties of circulating and tissue-resident human virus-specific αβ CD8(+) T cells.Understanding the CD28/CTLA-4 (CD152) pathway and its implications for costimulatory blockade.Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?CD28 Costimulation: From Mechanism to Therapy.T Cell Cosignaling Molecules in Transplantation.Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients.Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.
P2860
Q24295841-B77EE400-E4A7-4479-8B46-3A2CFDAE1C47Q26864888-A6A4360C-256F-4AA4-90E3-11407C1CEB02Q27007031-5EE15494-C39D-4C30-8EE8-B6BB92ED8732Q27021141-0D7F11CE-A39D-43D0-9438-1E1E5AAC5EAAQ27340853-93680CAA-C2B8-4F66-B306-82D030E79C41Q28394869-AA4328C6-B5A5-4603-9ABD-4D7F5292F4FAQ33573593-C370B554-3976-4861-B0BF-5E2EEDE8D5BAQ34274950-D72E9025-2B7B-46CA-9419-035846DBBCD4Q34748489-D2744764-E6F1-41D5-B9AE-EFA8C80E1D59Q35223235-CDEC6A37-F71E-4201-90CA-9FE82015B42BQ35826538-15F44D79-065C-4DE8-8079-C8FA8DF72969Q35928357-B7649CE9-1765-4F09-A8EB-B69890F4064DQ36584814-AC442258-C4E6-41C9-8955-EF5D4E6B1478Q36588716-54824707-6118-4B04-8316-81922FD382B1Q36839780-5B8A5C09-C463-499F-BC4C-ADF9AFDD9847Q36932447-44F3FB04-7C90-42FC-94B0-C499BEE66DA7Q36973787-02890704-DC2D-4DC5-B887-2216F43636D6Q37012600-F264B1DA-376D-4973-8B74-EA4CA420745DQ37375148-CEC5ED1C-D445-464A-82A2-D385FD4D37E3Q37651860-54D6F801-C000-41FF-90A0-6E06699431DFQ37923993-3E20BD32-6501-42C4-B221-E64AE62AB5B8Q37965932-F67649C0-2619-4F07-94E5-3B79B32BDD91Q37988965-65782EE2-6EEE-4163-8F4B-10D833554561Q37999397-041EF35B-CD36-4E9F-A726-BBD3B8EB8F16Q38040302-FD704757-FB4B-41A0-905E-4EAC56C7AAA9Q38044759-5A04256F-EABF-47C8-9FE0-BD3EDEF45595Q38129635-6C110E03-BC38-448E-8974-5EDFD75A6E51Q38150101-2545B02F-2BDC-45C5-8A76-C9323CEC56D2Q38160477-DA613551-C35C-4C35-81C6-84B5484FB120Q38170479-8A51EAE9-351F-4C1C-A116-8B7ACD72F533Q38180622-3C20EA10-69C0-4EE7-AD87-9F1A3CC84B5FQ38237428-C5C87D65-E0BF-47C0-BEA7-BF8C301994E6Q38681685-60688916-0D35-4D61-9140-1C72C6FCE02CQ38804454-238592A6-CF96-48E2-BEDF-B35C2BFE787AQ38837466-14F740BB-7A41-4881-98B3-1081F0BA1577Q38837473-C40082EA-DC55-4DEB-93F4-A589F955FDDDQ39133222-32121941-52F0-4A8B-BC3D-B65373BC3A1CQ39172891-F21B4608-2489-40AF-9420-EB4E068665F4Q39312652-B2020A94-67D3-4920-A050-4353C84C5660Q39432561-BE3727E5-5C8C-4A0C-BAA4-633E3F20F6DE
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
B7-h2 is a costimulatory ligand for CD28 in human
@ast
B7-h2 is a costimulatory ligand for CD28 in human
@en
B7-h2 is a costimulatory ligand for CD28 in human
@nl
type
label
B7-h2 is a costimulatory ligand for CD28 in human
@ast
B7-h2 is a costimulatory ligand for CD28 in human
@en
B7-h2 is a costimulatory ligand for CD28 in human
@nl
prefLabel
B7-h2 is a costimulatory ligand for CD28 in human
@ast
B7-h2 is a costimulatory ligand for CD28 in human
@en
B7-h2 is a costimulatory ligand for CD28 in human
@nl
P2093
P2860
P1433
P1476
B7-h2 is a costimulatory ligand for CD28 in human
@en
P2093
Dallas Flies
Diana J Goode
Gefeng Zhu
Haiying Xu
Lieping Chen
Linghua Zheng
Mathew Augustine
Megan Broadwater
Sarah Flies
P2860
P304
P356
10.1016/J.IMMUNI.2011.03.014
P407
P577
2011-04-28T00:00:00Z